# A Trial Using Double-Bolus THR-100 Versus Streptokinase

> **NCT01305226** · PHASE3 · COMPLETED · sponsor: **Bharat Biotech International Limited** · enrollment: 120 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** THR-100
- **DRUG:** Streptokinase

## Key facts

- **NCT ID:** NCT01305226
- **Lead sponsor:** Bharat Biotech International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305226, "A Trial Using Double-Bolus THR-100 Versus Streptokinase". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01305226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*